New research uncovers how cancer therapies are escalating heart disease risk among older adults, spotlighting the need for better monitoring. Study: Cardiovascular disease and stroke following cancer and cancer treatment in older adults. Image Credit: Tom Wanniwant / Shutterstock.
com A recent study published in the journal Cancer examines the risk of cardiovascular disease (CVD) in older adults who have undergone cancer treatment. The challenges cancer survivors face after treatment Recent advancements in cancer treatment have significantly improved survival rates and extended life expectancies of patients. However, cancer survivors are at a greater risk of future disease, including CVDs, related to either the cancer or its treatment as compared to the general population.
In fact, cancer patients are twice as likely to die of CVD. As a result, cancer patients, particularly those who have been prescribed cardiotoxic drugs, can be closely monitored to identify and manage their risk factors for CVD, alter treatment strategies, screen for heart abnormalities before and during treatment, and support physical exercise. Nevertheless, these monitoring strategies are not routinely incorporated into the healthcare plan for treating all cancer patients.
About the study Data for the current study were acquired from the Aspirin in Reducing Events in the Elderly (ASPREE) trial to assess how cancer and cancer treatment impact a composite CVD endpoint in elderly cancer patients. The ASPREE t.
